NCT07254195Recruiting
Assessment of an Intensive Motor Telerehabilitation Program for Stroke Patients
Intensive Motor Rehabilitation of Stroke Patients: Evaluation of a Telerehabilitation Program
Source: ClinicalTrials.gov · Last updated 5 Mar 2026
Brief summary (registry, in English)
Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery. However, after hospitalization, access to intensive rehabilitation is limited, due to geographical and mobility constraints, and the lack of reimbursement for private occupational therapy. Telerehabilitation, using digital technologies, can overcome these difficulties by offering interactive, accessible rehabilitation at home. Studies show that its effectiveness is comparable to that of clinical rehabilitation. Our study therefore proposes to evaluate the feasibility and effects of a home-based telerehabilitation program using the MindMotion GO device (MindMaze). This 12-week program aims to provide an additional intensive dose of rehabilitation to the standard of care, with 300 minutes of weekly active therapy, planned and monitored remotely by a therapist.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 51 (estimated)
- First submitted
- 19 Nov 2025
- Start date
- 25 Feb 2026
- Primary completion date
- 25 Jan 2028
- Lead sponsor
- Hospices Civils de Lyon
- Diseases
- Stroke
- NCT number
- NCT07254195
What you commit to
- Study type: Interventional
- Planned participants: 51
- From 25 Feb 2026 to the primary completion date, 25 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of stroke
- Neurological pathology other than stroke
- Patient with uncontrolled epilepsy or seizure disorder
- Cardiac disease limiting exercise
- Major comprehension problems or severe psychiatric and/or cognitive disorders that could compromise understanding of the protocol and the smooth running of the study.
- Severe memory impairment
Other
- Pain limiting rehabilitation dose
- Uncorrected hearing or visual deficits
- Severe apraxia
- Severe unilateral spatial neglect
- Total plegia of affected limb
- Pregnant, parturient or breast-feeding women
- Persons deprived of their liberty by judicial or administrative decision
- Persons admitted to a health or social institution for purposes other than research
- Adults under legal protection (guardianship, curatorship)
- Subjects participating in other intervention research.
Who the study is looking for
- Hospitalized for a first ischemic or hemorrhagic stroke
- Stroke occurrence more than 30 days prior
- Presenting motor deficits affecting the upper limb, with or without involvement of the lower limb
- Able to follow the instructions of the home program using the MindMotion GO device
- Having at home an accessible email address, an Internet connection with password, a smartphone, a screen or TV with HDMI input (Full HD 1080p resolution), and a free space of approximately 1 m x 2.5 m in front of the screen
- Ability to sit without assistance
- Patient agreeing to participate in the study by signing an informed consent form
- Affiliated with, or entitled to, a social security scheme
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Henry Gabrielle Coordinator of this site? Confirm its status | Saint-Genis-Laval | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.